CONCOMITANT CHEMORADIOTHERAPY FOR NONSMALL CELL LUNG-CANCER

被引：3
|
作者：
VOKES, EE
HARAF, DJ
HOFFMAN, PC
BITRAN, JD
FERGUSON, MK
GOLOMB, HM
机构：
[1] UNIV CHICAGO,DEPT SURG,CHICAGO,IL 60637
[2] LUTHERAN GEN HOSP,DEPT MED,PARK RIDGE,IL 60068
[3] UNIV CHICAGO,DEPT RADIAT & CELLULAR ONCOL,CHICAGO,IL 60637
来源：
LUNG CANCER | 1994年 / 10卷
关键词：
CONCOMITANT CHEMORADIOTHERAPY; NONSMALL CELL LUNG CANCER;
D O I：
10.1016/0169-5002(94)91689-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Concomitant chemoradiotherapy represents an investigational approach to the treatment of locoregionally advanced non-small cell lung cancer. The theoretical rationale, and clinical experience are reviewed in brief. Clinical trials conducted at the University of Chicago are summarized.
引用
收藏
页码：S253 / S261
页数：9
相关论文
共 50 条
  • [41] RADICAL RADIOTHERAPY FOR EARLY NONSMALL CELL LUNG-CANCER
    GRAHAM, PH
    GEBSKI, VJ
    STAT, M
    LANGLANDS, AO
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (02): : 261 - 266
  • [42] FEASIBILITY OF CURATIVE RADIOTHERAPY WITH A CONCOMITANT BOOST TECHNIQUE IN 33 PATIENTS WITH NONSMALL CELL LUNG-CANCER (NSCLC)
    SCHUSTERUITTERHOEVE, ALJ
    HULSHOF, MCCM
    GONZALEZ, DG
    KOOLEN, M
    SMINIA, P
    RADIOTHERAPY AND ONCOLOGY, 1993, 28 (03) : 247 - 251
  • [43] SHOULD NONSMALL CELL-CARCINOMA OF THE LUNG BE TREATED WITH CHEMOTHERAPY - PRO - CHEMOTHERAPY IS FOR NONSMALL CELL LUNG-CANCER
    MASTERS, GA
    VOKES, EE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (05) : 1285 - 1287
  • [44] HYDRAZINE SULFATE IN NONSMALL-CELL LUNG-CANCER - REPLY
    PIANTADOSI, S
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) : 1118 - 1118
  • [45] TRIMETREXATE AND CYCLOPHOSPHAMIDE FOR METASTATIC INOPERABLE NONSMALL CELL LUNG-CANCER
    MATTSON, K
    MAASILTA, P
    TAMMILEHTO, L
    HOLSTI, LR
    GROVE, W
    SEMINARS IN ONCOLOGY, 1988, 15 (02) : 32 - 37
  • [46] TRIALS WITH MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NONSMALL CELL LUNG-CANCER
    CULLEN, MH
    LUNG CANCER, 1995, 12 : S95 - S106
  • [47] NEW CHEMOTHERAPEUTIC-AGENTS FOR NONSMALL CELL LUNG-CANCER
    MILLER, VA
    RIGAS, JR
    GRANT, SC
    PISTERS, KMW
    KRIS, MG
    CHEST, 1995, 107 (06) : S306 - S311
  • [48] VARIATIONS IN THE MANAGEMENT AND OUTCOME OF NONSMALL CELL LUNG-CANCER IN ONTARIO
    MACKILLOP, WJ
    DIXON, P
    ZHOU, Y
    AGO, CT
    EGE, G
    HODSON, DI
    KOTALIK, JF
    LOCHRIN, C
    PASZAT, L
    HARRIS, D
    RADIOTHERAPY AND ONCOLOGY, 1994, 32 (02) : 106 - 115
  • [49] NEUROENDOCRINE DIFFERENTIATION AS A PROGNOSTIC FACTOR IN NONSMALL CELL LUNG-CANCER
    CARLES, J
    ROSELL, R
    ARIZA, A
    PELLICER, I
    SANCHEZ, JJ
    FERNANDEZVASALO, G
    ABAD, A
    BARNADAS, A
    LUNG CANCER, 1993, 10 (3-4) : 209 - 219
  • [50] PREOPERATIVE CONCOMITANT CISPLATIN VP16 AND RADIOTHERAPY IN STAGE-III NONSMALL CELL LUNG-CANCER
    PALAZZI, M
    CATALDO, I
    GRAMAGLIA, A
    DETOMA, D
    MILANI, F
    RAVASI, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03): : 621 - 625
12345